NCT07869589

Brief Summary

This randomized, sham-controlled clinical trial will evaluate the effectiveness of acupuncture at bilateral LI4 and SP6 as an adjunct to standard postoperative analgesia for acute pain after cesarean delivery. Women undergoing cesarean delivery under spinal anesthesia will be randomly assigned to receive either real acupuncture at bilateral LI4 and SP6 or sham acupuncture using non-penetrating Park sham needles. The acupuncture or sham intervention will be administered at the third postoperative hour. All participants will receive a standardized postoperative analgesic regimen, with additional rescue analgesia available when clinically required. The primary outcome will be pain intensity during first postoperative ambulation at the sixth postoperative hour, measured using a 0-10 visual analog scale (VAS). Secondary outcomes will include pain at rest and during movement at predefined postoperative time points, functional performance during first mobilization, rescue analgesic requirements, and acupuncture-related adverse events. Participant blinding will also be assessed after completion of the 24-hour outcome assessments.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Nov 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 9, 2026

Completed
23 days until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

October 9, 2026

Status Verified

October 1, 2026

Enrollment Period

8 months

First QC Date

October 4, 2026

Last Update Submit

October 4, 2026

Conditions

Keywords

Cesarean DeliveryPostoperative PainAcupunctureLI4SP6Sham AcupuncturePain ManagementEarly Mobilization

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity During First Postoperative Ambulation

    Pain intensity during the first postoperative ambulation will be assessed using a 0-10 visual analog scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain. First ambulation will be performed at the sixth postoperative hour and will include progression from sitting at the bedside to standing and walking. Participants will rate the pain experienced during the first ambulation, with higher scores indicating greater pain intensity.

    At the 6th postoperative hour

Secondary Outcomes (12)

  • Cumulative Resting Pain Burden (VAS AUC)

    From the 3rd to the 24th postoperative hour

  • Cumulative Movement-Evoked Pain Burden (VAS AUC)

    From the 3rd to the 24th postoperative hour

  • Postoperative Pain Intensity at Rest

    At the 3rd, 4th, 6th, 12th, and 24th postoperative hours

  • Postoperative Movement-Evoked Pain Intensity

    At the 3rd, 4th, 12th, and 24th postoperative hours

  • Number of Steps During First Postoperative Ambulation

    At the 6th postoperative hour

  • +7 more secondary outcomes

Study Arms (2)

LI4 + SP6 Acupuncture

EXPERIMENTAL

Participants will receive a single session of bilateral acupuncture at LI4 (Hegu) and SP6 (Sanyinjiao) at the third postoperative hour after cesarean delivery. Sterile acupuncture needles will be inserted at the four acupuncture sites and manually stimulated to elicit de qi. The needles will remain in place for 15 minutes. Participants will receive the standardized postoperative analgesic regimen used in the study, with rescue analgesia available when clinically required.

Procedure: LI4 + SP6 Acupuncture

Sham Acupuncture

SHAM COMPARATOR

Participants will receive a single sham acupuncture session at the third postoperative hour after cesarean delivery. Non-penetrating Park sham needles will be applied bilaterally at the same LI4 (Hegu) and SP6 (Sanyinjiao) locations used in the real acupuncture group, without skin penetration. The number of application sites, treatment duration (15 minutes), participant positioning, and practitioner interaction will be standardized to match the real acupuncture group. Participants will receive the same standardized postoperative analgesic regimen and rescue analgesia protocol as the acupuncture group.

Procedure: Park Sham Acupuncture

Interventions

A single acupuncture session will be administered at the third postoperative hour after cesarean delivery. Sterile acupuncture needles (0.25 × 25 mm) will be inserted bilaterally at LI4 (Hegu) and SP6 (Sanyinjiao), for a total of four acupuncture sites. Needles will be inserted to an approximate depth of 1.5-2 cm and manually stimulated to elicit de qi. The needles will remain in place for 15 minutes.

LI4 + SP6 Acupuncture

A single sham acupuncture session will be administered at the third postoperative hour after cesarean delivery. Non-penetrating Park sham needles will be applied bilaterally at the same LI4 (Hegu) and SP6 (Sanyinjiao) locations used in the real acupuncture group, for a total of four application sites. The sham needles will not penetrate the skin. Treatment duration, participant positioning, and practitioner interaction will be standardized to match the real acupuncture procedure. The sham needles will remain in place for 15 minutes.

Sham Acupuncture

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 18-50 years
  • Undergoing elective cesarean delivery under spinal anesthesia
  • Able to understand and use the 0-10 visual analog scale (VAS)
  • Able to provide written informed consent

You may not qualify if:

  • Emergency cesarean delivery
  • Conversion from spinal to general anesthesia or requirement for general anesthesia
  • Known allergy or contraindication to medications included in the standardized postoperative analgesic protocol
  • Presence of infection, skin lesion, or other condition preventing acupuncture or sham application at the LI4 or SP6 sites
  • Known bleeding disorder or clinically significant coagulation abnormality
  • Neurological, musculoskeletal, or other medical condition that would prevent or substantially limit postoperative mobilization
  • Chronic pain requiring regular analgesic medication
  • Regular opioid use before surgery
  • Inability to reliably assess or report pain intensity
  • Any postoperative clinical condition requiring deviation from the planned analgesic or mobilization protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Niğde Ömer Halisdemir University Hospital

Niğde, Niğde Province, 51240, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, PostoperativeAgnosia

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Central Study Contacts

Pınar Erdoğan, Assoc. Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants and outcome assessors will be blinded to treatment allocation. Real and sham procedures will be performed using a standardized protocol, with non-penetrating Park sham needles used in the sham group. The practitioner administering the acupuncture or sham procedure cannot be blinded because of the nature of the intervention and will not participate in postoperative pain or functional outcome assessments. Participant blinding will be evaluated after completion of the 24-hour outcome assessments by asking participants whether they believe they received real acupuncture, sham acupuncture, or are unsure. The statistical analysis will be performed using coded treatment groups.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc Prof

Study Record Dates

First Submitted

October 4, 2026

First Posted

October 9, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

October 9, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the results reported in the published article may be shared with qualified researchers upon reasonable request to the corresponding author, subject to review and approval of the proposed use and applicable ethical and institutional requirements.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
De-identified IPD and supporting information will be available beginning 6 months after publication of the primary study results and will remain available for 5 years.
Access Criteria
De-identified IPD and supporting information may be made available to qualified researchers who submit a methodologically sound proposal. Requests should be directed to the corresponding author and will be reviewed by the study investigators. Data will be provided for approved research purposes, subject to applicable ethical, institutional, and data-protection requirements. A data use agreement may be required before access is granted.

Locations